Cash and cash equivalents were $8.3 billion as of June 30, 2026
As of June 30, 2026, there were no borrowings outstanding under the $5.0 billion revolving credit agreement and no commercial paper outstanding
Cash flows provided by operating activities increased by $3.6 billion for the six months ended June 30, 2026 compared to H1 2025
Management had remaining authority to repurchase approximately $0.6 billion of common stock under the October 2023 program
no findingread · nothing bore on it
It held on this filing. No finding was written because nothing in it bore on the reason — the sentences it was read against are below.
the evidence · every sentence checkedfour sentences · whole, uncut
the claims it rests on
“Cash and cash equivalents were $8.3 billion as of June 30, 2026”
“As of June 30, 2026, there were no borrowings outstanding under the $5.0 billion revolving credit agreement and no commercial paper outstanding”
“Cash flows provided by operating activities increased by $3.6 billion for the six months ended June 30, 2026 compared to H1 2025”
“Management had remaining authority to repurchase approximately $0.6 billion of common stock under the October 2023 program”